Après is a food-scanning app for iOS that identifies FODMAP triggers in meals using AI-powered image and text analysis.
The App DNA
What makes this app unique?
The app removes the cognitive friction of manual ingredient research for users managing IBS, replacing complex food diaries with instant trigger scoring.
For Individuals managing IBS or low-FODMAP diets who require tools to identify trigger foods and digestive support.
What does it look like?
Key features
Uses camera input to identify meal components and calculate a FODMAP trigger score from 0 to 10.
Adapts trigger scores based on user-logged symptom check-ins over time.
Displays specific presence of lactose, fructose, fructans, GOS, sorbitol, and mannitol in scanned foods.
How much does it cost?
The subscription model anchors Après as a retention tool for physical digestive enzymes, locking the software behind a physical purchase.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app maintains a maintenance-level cadence, shipping approximately 0.23 releases per week. The latest release provides only generic bug fixes and improvements, continuing a trend of minimal development activity. There is no evidence of new features or live-ops content, suggesting the current focus is strictly on stability and technical upkeep.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Après - FODMAP Scanner
How's the Health & Fitness market?
Après operates in the Health & Fitness category as a specialized diagnostic tool. The current model, which gates software access behind a physical enzyme subscription, limits the addressable market to users willing to commit to a $34/month physical product.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Après - FODMAP Scanner
Where is it heading?
The low-FODMAP diet market is consolidating around tools that minimize logging friction. Après is well-positioned for high-intent users, but its growth is constrained by the physical-enzyme dependency, which limits the addressable audience to those seeking a full-cycle digestive solution.
- The current maintenance-only release cadence suggests a focus on stability over rapid feature expansion, which keeps the product stable but limits growth.
- The integration of AI-powered image scanning provides a clear utility that differentiates the app from manual-entry competitors, creating a defensible niche.
The SWOT
- AI-powered image recognition reduces logging friction
- Compound-level breakdown provides actionable diagnostic data
- Standalone digital subscription tier for broader reach
Next best moves
Pivot the pricing strategy to offer a standalone digital-only subscription because the current physical-enzyme bundle limits the top-of-funnel conversion → increase user acquisition velocity.
+ 1 more prioritized moveThe counter-intuitive read
The physical-enzyme bundle is not a weakness but…
Read the full takeSince the last report: The developer has initiated a strategic pivot to decouple software access from physical enzyme subscriptions to lower the entry barrier for new users. This shift marks a transition from viewing the app as a retention tool to treating it as a standalone digital product.
Bottom line
Après provides a specialized diagnostic utility that justifies its premium price for users with severe IBS, but the physical-enzyme dependency caps the potential user base. Decoupling the software from the physical product would unlock a wider audience of casual diet-trackers.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store listing, source
Report last updated